These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6740089)

  • 1. Control of poliomyelitis in Africa.
    Foster SO; Kesseng-Maben G; N'jie H; Coffi E
    Rev Infect Dis; 1984; 6 Suppl 2():S433-7. PubMed ID: 6740089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral poliovirus vaccine in tropical Africa: greater impact on incidence of paralytic disease than expected from coverage surveys and seroconversion rates.
    Heymann DL; Murphy K; Brigaud M; Aymard M; Tembon A; Maben GK
    Bull World Health Organ; 1987; 65(4):495-501. PubMed ID: 3500802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenge of poliomyelitis in tropical Africa.
    Ofosu-Amaah S
    Rev Infect Dis; 1984; 6 Suppl 2():S318-20. PubMed ID: 6740067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an endemic disease. II. Clinical efficacy of trivalent oral polio vaccine.
    Deming MS; Jaiteh KO; Otten MW; Flagg EW; Jallow M; Cham M; Brogan D; N'jie H
    Am J Epidemiol; 1992 Feb; 135(4):393-408. PubMed ID: 1550091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cluster survey evaluation of coverage and risk factors for failure to be immunized during the 1995 National Immunization Days in Egypt.
    Reichler MR; Darwish A; Stroh G; Stevenson J; Al Nasr MA; Oun SA; Wahdan MH
    Int J Epidemiol; 1998 Dec; 27(6):1083-9. PubMed ID: 10024208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliomyelitis in India: prospects and problems of control.
    John TJ
    Rev Infect Dis; 1984; 6 Suppl 2():S438-41. PubMed ID: 6740090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine coverage and determinants of incomplete vaccination in children aged 12-23 months in Dschang, West Region, Cameroon: a cross-sectional survey during a polio outbreak.
    Russo G; Miglietta A; Pezzotti P; Biguioh RM; Bouting Mayaka G; Sobze MS; Stefanelli P; Vullo V; Rezza G
    BMC Public Health; 2015 Jul; 15():630. PubMed ID: 26156158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The control of poliomyelitis in Brazil.
    Baptista Risi J
    Rev Infect Dis; 1984; 6 Suppl 2():S400-3. PubMed ID: 6740081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Poliomyelitis in 1973-1974 in France].
    Celers J; Cassaigne R; Brigaud M; Netter R
    Ann Pediatr (Paris); 1976 Sep; 23(8-9):537-40. PubMed ID: 16104189
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical efficacy of trivalent oral polio vaccine in The Gambia by season of vaccine administration.
    Deming MS; Linkins RW; Jaiteh KO; Hull HF
    J Infect Dis; 1997 Feb; 175 Suppl 1():S254-7. PubMed ID: 9203725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress toward poliomyelitis eradication--Africa, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Apr; 46(15):321-5. PubMed ID: 9132585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why has polio eradication program failed in India.
    Paul Y
    Indian Pediatr; 2008 May; 45(5):381-8. PubMed ID: 18515926
    [No Abstract]   [Full Text] [Related]  

  • 16. Poliomyelitis surveillance and vaccine efficacy in Bombay, 1982-87.
    Kim-Farley RJ; Dave KH; Sokhey J; Mandke VB
    Bull World Health Organ; 1989; 67(6):663-7. PubMed ID: 2633881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on the use of oral poliovirus vaccines in the Caribbean and Canada.
    Spence L
    Rev Infect Dis; 1984; 6 Suppl 2():S331-3. PubMed ID: 6740070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an endemic disease. I. Descriptive findings.
    Otten MW; Deming MS; Jaiteh KO; Flagg EW; Forgie I; Sanyang Y; Sillah B; Brogan D; Gowers P
    Am J Epidemiol; 1992 Feb; 135(4):381-92. PubMed ID: 1312772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded programme on immunization (EPI). Update: mass vaccination with oral poliovirus vaccine, Asia and Europe, 1996.
    Wkly Epidemiol Rec; 1996 Nov; 71(44):329-32. PubMed ID: 8962822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.